Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections

Vaccine

Volumn 35, Issue 5, 2017, Pages 747-756

  Hare, Kim M ^a   Smith Vaughan, Heidi C ^a   Chang, Anne B ^a,b   Pizzutto, Susan ^a   Petsky, Helen L ^b   McCallum, Gabrielle B ^a   Leach, Amanda J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b LADY CILENTO CHILDREN S HOSPITAL   (Australia)

Author keywords

Bronchiectasis; Chronic suppurative lung disease; Lower airway infection; Pneumococcal conjugate vaccine; Protracted bacterial bronchitis; Serotype infectiveness; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; ASYMPTOMATIC INFECTION; BRONCHIECTASIS; BRONCHITIS; BRONCHOSCOPY; CHILD; CHILDHOOD DISEASE; CHRONIC COUGH; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HUMAN; HUMAN TISSUE; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROPREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; VACCINATION; ADOLESCENT; BACTERIAL COUNT; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHUS; CHRONIC BRONCHITIS; COMPLICATION; IMMUNOLOGY; INFANT; MICROBIOLOGY; NASOPHARYNX; PATHOGENICITY; PATHOLOGY; PNEUMONIA; PRESCHOOL CHILD; SUPPURATION;

ADOLESCENT; BRONCHI; BRONCHIECTASIS; BRONCHITIS, CHRONIC; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; INFANT; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; SUPPURATION;

EID: 85008473106     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.12.059     Document Type: Article

References (49)

1. [1] Grimwood, K., Airway microbiology and host defences in paediatric non-CF bronchiectasis. Paediatr Respir Rev 12 (2011), 111–118.
2. [2] Chang, A.B., Upham, J.W., Masters, I.B., Redding, G.R., Gibson, P.G., Marchant, J.M., et al. Protracted bacterial bronchitis: the last decade and the road ahead. Pediatr Pulmonol 51 (2016), 225–242.
3. [3] Valery, P.C., Torzillo, P.J., Mulholland, K., Boyce, N.C., Purdie, D.M., Chang, A.B., Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 23 (2004), 902–908.
4. [4] Trenholme, A.A., Byrnes, C.A., McBride, C., Lennon, D.R., Chan-Mow, F., Vogel, A.M., et al. Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection. Pediatr Pulmonol 48 (2013), 772–779.
5. [5] Donnelly, D., Critchlow, A., Everard, M.L., Outcomes in children treated for persistent bacterial bronchitis. Thorax 62 (2007), 80–84.
6. [6] Marchant, J.M., Newcombe, P.A., Juniper, E.F., Sheffield, J.K., Stathis, S.L., Chang, A.B., What is the burden of chronic cough for families?. Chest 134 (2008), 303–309.
7. [7] Steinfort, D.P., Brady, S., Weisinger, H.S., Einsiedel, L., Bronchiectasis in Central Australia: a young face to an old disease. Respir Med 102 (2008), 574–578.
8. [8] Loebinger, M.R., Wells, A.U., Hansell, D.M., Chinyanganya, N., Devaraj, A., Meister, M., et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 34 (2009), 843–849.
9. [9] Black, S.B., Shinefield, H.R., Hansen, J., Elvin, L., Laufer, D., Malinoski, F., Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20 (2001), 1105–1107.
10. [10] Centers for Disease Control and Prevention, Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 59 (2010), 258–261.
11. [11] Barker, J., Gratten, M., Riley, I., Lehmann, D., Montgomery, J., Kajoi, M., et al. Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. J Infect Dis 159 (1989), 348–352.
12. [12] Smith, T., Lehmann, D., Montgomery, J., Gratten, M., Riley, I.D., Alpers, M.P., Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 111 (1993), 27–39.
13. [13] Brueggemann, A.B., Griffiths, D.T., Meats, E., Peto, T., Crook, D.W., Spratt, B.G., Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187 (2003), 1424–1432.
14. [14] Hanage, W.P., Kaijalainen, T.H., Syrjanen, R.K., Auranen, K., Leinonen, M., Makela, P.H., et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 73 (2005), 431–435.
15. [15] Sa-Leao, R., Pinto, F., Aguiar, S., Nunes, S., Carrico, J.A., Frazao, N., et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 49 (2011), 1369–1375.
16. [16] del Amo, E., Brotons, P., Monsonis, M., Trivino, M., Inigo, M., Selva, L., et al. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. Clin Microbiol Infect 20 (2014), 684–689.
17. [17] Horacio, A.N., Lopes, J.P., Ramirez, M., Melo-Cristino, J., Non-invasive pneumococcal pneumonia in Portugal–serotype distribution and antimicrobial resistance. PLoS ONE, 9, 2014, e103092.
18. [18] De Schutter, I., Malfroot, A., Pierard, D., Lauwers, S., Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines. Pediatr Pulmonol 41 (2006), 765–770.
19. [19] Priftis, K.N., Litt, D., Manglani, S., Anthracopoulos, M.B., Thickett, K., Tzanakaki, G., et al. Bacterial bronchitis caused by Streptococcus pneumoniae and nontypable Haemophilus influenzae in children: the impact of vaccination. Chest 143 (2013), 152–157.
20. [20] Mayanskiy, N., Alyabieva, N., Ponomarenko, O., Lazareva, A., Katosova, L., Ivanenko, A., et al. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Int J Infect Dis 20 (2014), 58–62.
21. [21] Leach, A.J., Wigger, C., Hare, K., Hampton, V., Beissbarth, J., Andrews, R., et al. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC Pediatr, 15, 2015, 162.
22. [22] Leach, A.J., Wigger, C., Beissbarth, J., Woltring, D., Andrews, R., Chatfield, M.D., et al. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 86 (2016), 224–232.
23. [23] Chang, A.B., Bell, S.C., Byrnes, C.A., Grimwood, K., Holmes, P.W., King, P.T., et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust 193 (2010), 356–365.
24. [24] Wurzel, D.F., Marchant, J.M., Yerkovich, S.T., Upham, J.W., Mackay, I.M., Masters, I.B., et al. Prospective characterisation of protracted bacterial bronchitis (PBB) in children. Chest 145 (2014), 1271–1278.
25. [25] Hare, K.M., Grimwood, K., Leach, A.J., Smith-Vaughan, H., Torzillo, P.J., Morris, P.S., et al. Respiratory bacterial pathogens in the nasopharynx and lower airways of australian indigenous children with bronchiectasis. J Pediatr 157 (2010), 1001–1005.
26. [26] Chang, A.B., Faoagali, J., Cox, N.C., Marchant, J.M., Dean, B., Petsky, H.L., et al. A bronchoscopic scoring system for airway secretions–airway cellularity and microbiological validation. Pediatr Pulmonol 41 (2006), 887–892.
27. [27] Leach, A.J., Morris, P.S., McCallum, G.B., Wilson, C.A., Stubbs, L., Beissbarth, J., et al. Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect Dis, 9, 2009, 121.
28. [28] Hare, K.M., Morris, P., Smith-Vaughan, H., Leach, A.J., Random colony selection versus colony morphology for detection of multiple pneumococcal serotypes in nasopharyngeal swabs. Pediatr Infect Dis J 27 (2008), 178–180.
29. [29] Hare, K.M., Leach, A.J., Morris, P.S., Smith-Vaughan, H., Torzillo, P., Bauert, P., et al. Impact of recent antibiotics on nasopharyngeal carriage and lower airway infection in Indigenous Australian children with non-cystic fibrosis bronchiectasis. Int J Antimicrob Agents 40 (2012), 365–369.
30. [30] Simpson, E.H., Measurement of diversity. Nature, 163, 1949, 688.
31. [31] Grundmann, H., Hori, S., Tanner, G., Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 39 (2001), 4190–4192.
32. [32] Venkateswaran, P.S., Stanton, N., Austrian, R., Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15. J Infect Dis 147 (1983), 1041–1054.
33. [33] van Selm, S., van Cann, L.M., Kolkman, M.A., van der Zeijst, B.A., van Putten, J.P., Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun 71 (2003), 6192–6198.
34. [34] Abdullahi, O., Karani, A., Tigoi, C.C., Mugo, D., Kungu, S., Wanjiru, E., et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis 206 (2012), 1020–1029.
35. [35] King, P.T., Hutchinson, P.E., Johnson, P.D., Holmes, P.W., Freezer, N.J., Holdsworth, S.R., Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med 167 (2003), 587–592.
36. [36] Pizzutto, S.J., Yerkovich, S.T., Upham, J.W., Hales, B.J., Thomas, W.R., Chang, A.B., Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae. PLoS ONE, 9, 2014, e104236.
37. [37] Satzke, C., Dunne, E., Porter, B.D., Antonio, M., O'Brien, K.L., Robins-Browne, R.M., et al. PneuCarriage project: identifying the optimum pneumococcal serotyping method(s), including detection of multiple serotype carriage. Pneumonia, 3, 2014, 63.
38. [38] Lai, J.Y., Cook, H., Yip, T.W., Berthelsen, J., Gourley, S., Krause, V., et al. Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010–2012. BMC Infect Dis, 13, 2013, 409.
39. [39] Gonzalez, B.E., Hulten, K.G., Lamberth, L., Kaplan, S.L., Mason, E.O. Jr., Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 25 (2006), 301–305.
40. [40] Jacobs, M.R., Good, C.E., Bajaksouzian, S., Windau, A.R., Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 47 (2008), 1388–1395.
41. [41] Martin, J.M., Hoberman, A., Paradise, J.L., Barbadora, K.A., Shaikh, N., Bhatnagar, S., et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 33 (2014), e286–e290.
42. [42] van der Linden, M., Perniciaro, S., Imohl, M., Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era. BMC Infect Dis, 15, 2015, 207.
43. [43] Beall, B., McEllistrem, M.C., Gertz, R.E. Jr., Boxrud, D.J., Besser, J.M., Harrison, L.H., et al. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J Infect Dis 186 (2002), 118–122.
44. [44] Henriqus Normark, B., Christensson, B., Sandgren, A., Noreen, B., Sylvan, S., Burman, L.G., et al. Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microbiol Drug Resist 9 (2003), 337–344.
45. [45] Gertz, R.E. Jr., Li, Z., Pimenta, F.C., Jackson, D., Juni, B.A., Lynfield, R., et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 201 (2010), 770–775.
46. [46] Mendes, R.E., Biek, D., Critchley, I.A., Farrell, D.J., Sader, H.S., Jones, R.N., Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011–2012: ceftaroline remains active in vitro among beta-lactam agents. Antimicrob Agents Chemother 58 (2014), 4923–4927.
47. [47] Hausdorff, W.P., Hoet, B., Adegbola, R.A., Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough. Expert Rev Vaccines 14 (2015), 413–428.
48. [48] Hanage, W.P., Auranen, K., Syrjanen, R., Herva, E., Makela, P.H., Kilpi, T., et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 72 (2004), 76–81.
49. [49] Sleeman, K.L., Griffiths, D., Shackley, F., Diggle, L., Gupta, S., Maiden, M.C., et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194 (2006), 682–688.